Results 21 to 30 of about 8,428 (249)

Adjunctive Pentoxifylline Enhances Clinical Remission and Reduces Inflammatory Biomarkers in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-Controlled Pilot Trial [PDF]

Pharmaceuticals
Background: Despite mesalamine’s efficacy in mild-to-moderate ulcerative colitis (UC), many patients fail to achieve complete clinical or biochemical remission.
Mohannad O. Khrieba, Furqan M. Abdulelah, Amal Mohammed Badawoud, Eman Hamza, Reham A. Al-Dhelaan, Tarek I. Ahmed, Ahmed G. Abdelhameed, Nora Elshorbagi, Doaa A. El-Hanafy, Nashwa Eltantawy, Muhammed M. Salahuddin, Noha M. Elkhodary, Kholoud H. Radwan, Khaled Abo Bakr Khalaf Ali, Abeer A. El-Sayed, Marwa Kamal   +15 more
doaj   +2 more sources

Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

Drug Design, Development and Therapy, 2014
David Pierce,1 Mary Corcoran,2 Patrick Martin,2 Karen Barrett,1 Susi Inglis,1 Peter Preston,2 Thomas N Thompson,3 Sandra K Willsie3 1Shire, Basingstoke, UK; 2Shire, Wayne, PA, USA; 3PRA International, Lenexa, KS, USA Background: MMX® mesalamine is a
Pierce D, Corcoran M, Martin P, Barrett K, Inglis S, Preston P, Thompson TN, Willsie SK   +7 more
doaj   +1 more source

Effect of mesalamine on healing in experimental colon anastomosis: A randomised experimental study

International Journal of Surgery, 2008
ObjectiveWe aimed to investigate the effect of mesalamine on healing of experimental colon anastomosis model.Material/MethodsForty adult male Wistar albino rats were performed segmentary colonic resection and end-to-end anastomosis. Animals were randomly
Ahmet Aslan, Muhyittin Temiz, Gurbuz Polat   +2 more
exaly   +2 more sources

Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes

Clinical Gastroenterology and Hepatology, 2020
Background & Aims: Little is known about the effects of discontinuing mesalamine therapy for patients with Crohn's disease (CD) who initiate therapy with an anti–tumor necrosis factor (anti-TNF) agent.
Ryan C Ungaro, Berkeley N Limketkai, Clara Yzet   +2 more
exaly   +2 more sources

Mesalamine-Induced Eosinophilic Pneumonia [PDF]

Cureus
Eosinophilic pneumonia encompasses a group of lung disorders characterized by peripheral blood eosinophilia. While its etiology is often idiopathic or infectious, non-infectious causes, including drug-induced reactions, should also be considered. Common culprits of drug-induced eosinophilic pneumonia include daptomycin, phenytoin, and nitrofurantoin ...
Sharma, Monish, Sotelo, Joseph E, Schultz, Steve   +2 more
openaire   +3 more sources

Cap Polyposis Mimicking Rectal Neoplasia in an Adolescent [PDF]

United European Gastroenterol J
United European Gastroenterology Journal, Volume 14, Issue 4, May 2026.
Meng Huang, Jie Wu
wiley   +2 more sources

Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome [PDF]

Clinical Gastroenterology and Hepatology
Background & Aims Some patients with irritable bowel syndrome (IBS) demonstrate low-grade inflammation in the intestine. Mesalamine, which has anti-inflammatory effects, may be an efficacious treatment for IBS, but studies are conflicting.
Vivek C Goodoory, Ashok K Tuteja, Christopher J Black   +2 more
exaly   +2 more sources

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine

Patient Preference and Adherence, 2009
Daniel B Zandman, Mark A PeppercornHarvard Medical School, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Mesalamine and its derivatives are effective and well-tolerated therapies for ...
Daniel B Zandman, Mark A Peppercorn
doaj   +1 more source

Drug-Induced Intersticial Nephritis. Clinical Case

Acta Medica Lituanica, 2021
5-Aminosalicylic acid (5-ASA) preparations are widely used in the treatment of inflammatory bowel diseases. The most commonly used medicine is mesalamine. Overall, it is a very safe drug with few side effects.
Paulina Tekoriutė, Monika Matuliauskaitė, Laimas Virginijus Jonaitis   +2 more
doaj   +1 more source

Design and biological evaluation of mesalamine–NSAID hybrids targeting the NLRP3 inflammasome: a multi-target strategy for ulcerative colitis therapy [PDF]

Sci Rep
Misagh Yahya, Javad Safaei‐Ghomi, Abdolrasoul Haghir-Ebrahimabadi, Hanieh Jalali, Hossein Mojtabazadeh   +4 more
openalex   +2 more sources